MEDICINE & HEALTH

remdesivir drug

Two-Thirds of Severely Ill Coronavirus Patients Recovered With Remdesivir But Experts Remain Doubtful

MEDICINE & HEALTH The Antiviral, Remdesivir from Gilead Sciences, sparks hope as a new study revealed two-thirds of severely ill coronavirus patients improved after the use of the drug. Although the results of the study seem promising, many experts believe that proof of the drug's effectivity is still lacking. To answer important questions, more studies need to be conducted on a wide variety of patients. Click the link above to find out more.

World, Meet Kizzmekia Corbett: Leader of Clinical Trial in Search of Coronavirus Vaccine

The National Institute of Health's Kizzmekia Corbett is the leader of the clinical trial in search of a vaccine for coronavirus. This young woman is praised by her superiors and is deemed as the "best fit" for the job. The first stages of the clinical trials started early in March and many are counting on her and her team to quickly come up with a cure to fight the pandemic. How does she handle all the stress? Click the link above to find out.

US Stops All Studies Involving Bats as It Cautions Against The Dangers of Possibly Triggering a New Wave Coronavirus Infection

The US government is now banning all research involving bats due to the fear of creating a bigger problem regarding the spread of infection. Still facing the intense battle against COVID-19, the US places effort on eliminating the possibility of transferring the virus to bats in Northern American species, which could cause further spread of the disease. Interested to find out more? Click the link above.

Recommended Stories